Evaluation of the introduction of novel potassium binders in routine care; the Stockholm CREAtinine measurements (SCREAM) project.

Ailema Gonzalez-OrtizCatherine M ClaseAlessandro BosiEdouard L FuBeatriz E Pérez-GuilléAnne-Laure FauconMarie EvansCarmine ZoccaliJuan Jesús Carrero

Published in: Journal of nephrology (2024)

We observed similar short-term effectiveness and safety for all potassium binders. However, treatment duration was longer for novel binders than for sodium polystyrene sulfonate.

Keyphrases

quality improvement
healthcare
clinical practice
uric acid
metabolic syndrome
health insurance